98 related articles for article (PubMed ID: 6220269)
21. Gynaecomastia as a presenting feature of thyrotoxicosis.
Chan WB; Yeung VT; Chow CC; So WY; Cockram CS
Postgrad Med J; 1999 Apr; 75(882):229-31. PubMed ID: 10715765
[TBL] [Abstract][Full Text] [Related]
22. Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase.
Castro-Magana M; Angulo M; Uy J
N Engl J Med; 1993 May; 328(18):1297-301. PubMed ID: 8469252
[TBL] [Abstract][Full Text] [Related]
23. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
24. Kinetics and effect of percutaneous administration of dihydrotestosterone in children.
Charmandari E; Dattani MT; Perry LA; Hindmarsh PC; Brook CG
Horm Res; 2001; 56(5-6):177-81. PubMed ID: 11910204
[TBL] [Abstract][Full Text] [Related]
25. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.
Wang C; Iranmanesh A; Berman N; McDonald V; Steiner B; Ziel F; Faulkner SM; Dudley RE; Veldhuis JD; Swerdloff RS
J Clin Endocrinol Metab; 1998 Aug; 83(8):2749-57. PubMed ID: 9709942
[TBL] [Abstract][Full Text] [Related]
26. Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemo-radiotherapy.
Harris E; Mahendra P; McGarrigle HH; Linch DC; Chatterjee R
Bone Marrow Transplant; 2001 Dec; 28(12):1141-4. PubMed ID: 11803356
[TBL] [Abstract][Full Text] [Related]
27. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
Mårin P; Krotkiewski M; Björntorp P
Eur J Med; 1992 Oct; 1(6):329-36. PubMed ID: 1341460
[TBL] [Abstract][Full Text] [Related]
28. Sex differences in brain and plasma beta-endorphin content following testosterone, dihydrotestosterone and estradiol administration to gonadectomized rats.
Pluchino N; Ninni F; Casarosa E; Giannini A; Merlini S; Cubeddu A; Luisi M; Cela V; Genazzani AR
Neuroendocrinology; 2009; 89(4):411-23. PubMed ID: 19295188
[TBL] [Abstract][Full Text] [Related]
29. Effect of gegen-tang on painful gynecomastia in patients with liver cirrhosis: a brief report.
Motoo Y; Taga H; Su SB; Sawabu N
Am J Chin Med; 1997; 25(3-4):317-24. PubMed ID: 9358905
[TBL] [Abstract][Full Text] [Related]
30. On the role of dihydrotestosterone in regulating luteinizing hormone secretion in man.
Schaison G; Renoir M; Lagoguey M; Mowszowicz I
J Clin Endocrinol Metab; 1980 Nov; 51(5):1133-7. PubMed ID: 6106650
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial.
Perdonà S; Autorino R; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Bianco AR; Di Lorenzo G
Lancet Oncol; 2005 May; 6(5):295-300. PubMed ID: 15863377
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
Meier C; Liu PY; Ly LP; de Winter-Modzelewski J; Jimenez M; Handelsman DJ; Seibel MJ
J Clin Endocrinol Metab; 2004 Jun; 89(6):3033-41. PubMed ID: 15181095
[TBL] [Abstract][Full Text] [Related]
33. Familial external genital ambiguity due to a transformation defect of androgen-receptor complexes that is expressed with 5 alpha-dihydrotestosterone and the synthetic androgen methyltrienolone.
Kaufman M; Pinsky L; Bowin A; Au MW
Am J Med Genet; 1984 Jul; 18(3):493-507. PubMed ID: 6332533
[TBL] [Abstract][Full Text] [Related]
34. Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study.
Biglia A; Blanco JL; Martínez E; Domingo P; Casamitjana R; Sambeat M; Milinkovic A; Garcia M; Laguno M; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM
Clin Infect Dis; 2004 Nov; 39(10):1514-9. PubMed ID: 15546089
[TBL] [Abstract][Full Text] [Related]
35. Safety aspects of androgen treatment with 5alpha-dihydrotestosterone.
Sakhri S; Gooren LJ
Andrologia; 2007 Dec; 39(6):216-22. PubMed ID: 18076420
[TBL] [Abstract][Full Text] [Related]
36. The role of tamoxifen in the management of gynaecomastia.
Hanavadi S; Banerjee D; Monypenny IJ; Mansel RE
Breast; 2006 Apr; 15(2):276-80. PubMed ID: 15998589
[TBL] [Abstract][Full Text] [Related]
37. [Gynecomastia and dihydrotestosterone].
Ménagé JJ; Neel JL
Sem Hop; 1976 Dec; 52(42):2431-2. PubMed ID: 191926
[No Abstract] [Full Text] [Related]
38. [Basal prolactinemia and level after stimulation with TRH in juvenile gynecomastia].
Lo Giudice C; Valmachino G; Manente P; Fioretti D; Gasparoni P; Spinella P; Borsato N; Conte N
Minerva Med; 1980 Oct; 71(41):2997-303. PubMed ID: 6779241
[TBL] [Abstract][Full Text] [Related]
39. Effect of 5alpha-dihydrotestosterone implants on the fertility of male rats treated with tamoxifen.
Parte PP; Balasinor N; Gill-Sharma MK; Juneja HS
J Androl; 2000; 21(4):525-33. PubMed ID: 10901438
[TBL] [Abstract][Full Text] [Related]
40. Transdermal dihydrotestosterone treatment of 'andropause'.
de Lignieres B
Ann Med; 1993 Jun; 25(3):235-41. PubMed ID: 7687444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
